生物科技公司BioLife Solutions（BLFS）今日盘中大涨5.43%，引发市场关注。消息面上，公司发布的最新季度财报显示业绩超出市场预期。
根据BioLife Solutions公布的财报，截至6月30日的季度调整后每股亏损为1美分，好于分析师平均预期的亏损4美分。公司营收达2542万美元，虽同比下降10.3%，但仍高于分析师预期的2371万美元。这一业绩表现说明公司在当前经济环境下仍保持了一定的韧性。
值得注意的是，这一财报结果标志着BioLife Solutions连续第二个季度业绩好于预期。此前一个季度公司每股亏损1美分，也优于市场预期的亏损5美分。公司业绩的持续改善提振了投资者信心，推动股价上涨。尽管如此，BioLife Solutions今年以来股价仍下跌了18.8%，显示公司仍面临一定的经营压力。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.